Pulmonology Medical News about cystic fibrosis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Extracellular DNA and F-actin as targets in antibiofilm cystic fibrosis therapy
Future Microbiology, 08/19/09

Tolker–Nielsen T et al. – The synergistic effect of the combined polyvalent anion–DNase treatment is most likely due to the capacity of polyvalent anions to dissociate DNA/F–actin bundles with bacteria and polysaccharides, leading to exposure of a greater number of DNase cleavage sites on the extracellular DNA. It is conceivable that treatment with soluble polyvalent anions as an adjunct to DNase treatment will represent an improvement in cystic fibrosis therapy.

<< Previous
High-dose prednisolone and bolus cyclophosphamide in interstitial...

Next >>
Effect of environmental allergen sensitization on asthma...

Vitamin D supplementation for cystic fibrosis
Cochrane Reviews, 10/28/09 Relevance Score: 69%

Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis
Gastroenterology, 10/27/09 Relevance Score: 69%

Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Inspire, 10/16/09 Relevance Score: 69%

Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09 Relevance Score: 69%

Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation
European Respiratory Journal, 10/23/09 Relevance Score: 68%